1-17 of 17
Richard Kremer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3913: New insights from transgenic mouse models of PyMT-induced breast cancer: identifying novel long non-coding RNA biomarkers

Rui Zhang, Jiarong Li, Dunarel Badescu, Jiannis Ragoussis, Richard Kremer
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 3913.
https://doi.org/10.1158/1538-7445.AM2025-3913
Published: 21 April 2025
View articletitled, Abstract 3913: New insights from transgenic mouse models of PyMT-induced breast cancer: identifying novel long non-coding RNA biomarkers
Journal Articles

Abstract 4657: Investigating the role of circulating bone cells in melanoma patients on immune checkpoint inhibitor therapy

Nicholas Rozza, Catalin Mihalcioiu, Richard Kremer
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 4657.
https://doi.org/10.1158/1538-7445.AM2025-4657
Published: 21 April 2025
View articletitled, Abstract 4657: Investigating the role of circulating bone cells in melanoma patients on immune checkpoint inhibitor therapy
Journal Articles

Abstract PR09: Pancreatic cancer cachexia is mediated by tumor-derived PTHrP

Yamini Ogoti, Jessica Peura, Calvin Johnson, Ekaterina Korobkina, Maximilian Wengyn, Robert J. Norgard, Richard Kremer, David A. Guertin, Jason R. Pitarresi
Journal: Cancer Research
Cancer Res (2024) 84 (2_Supplement): PR09.
https://doi.org/10.1158/1538-7445.PANCA2023-PR09
Published: 16 January 2024
View articletitled, Abstract PR09: Pancreatic cancer cachexia is mediated by tumor-derived PTHrP
Journal Articles

Abstract PR-010: Collateral amplification of the KRAS linked gene PTHLH governs pancreatic cancer growth and metastasis and reveals a new therapeutic vulnerability

Jason R. Pitarresi, Robert J. Norgard, Anna M. Chiarella, Kensuke Suzuki, Richard Kremer, Ben Z. Stanger, Anil K. Rustgi
Journal: Cancer Research
Cancer Res (2021) 81 (22_Supplement): PR-010.
https://doi.org/10.1158/1538-7445.PANCA21-PR-010
Published: 15 November 2021
View articletitled, Abstract PR-010: Collateral amplification of the KRAS linked gene PTHLH governs pancreatic cancer growth and metastasis and reveals a new therapeutic vulnerability
Journal Articles

Abstract 2861: Collateral amplification KRAS-PTHrP drives pancreatic cancer growth and metastasis and reveals a new therapeutic vulnerability

Jason Robert Pitarresi, Robert J. Norgard, Anna M. Chiarella, Richard Kremer, Ben Z. Stanger, Anil K. Rustgi
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 2861.
https://doi.org/10.1158/1538-7445.AM2021-2861
Published: 01 July 2021
View articletitled, Abstract 2861: Collateral amplification KRAS-PTHrP drives pancreatic cancer growth and metastasis and reveals a new therapeutic vulnerability
Journal Articles

Abstract PO-057: Collateral amplification of the PTHrP gene drives pancreatic cancer growth and metastasis and reveals a new therapeutic vulnerability

Jason R. Pitarresi, Robert J. Norgard, Anna M. Chiarella, Richard Kremer, Ben Z. Stanger, Anil K. Rustgi
Journal: Cancer Research
Cancer Res (2020) 80 (22_Supplement): PO-057.
https://doi.org/10.1158/1538-7445.PANCA20-PO-057
Published: 13 November 2020
View articletitled, Abstract PO-057: Collateral amplification of the PTHrP gene drives pancreatic cancer growth and metastasis and reveals a new therapeutic vulnerability
Journal Articles

Abstract 520: Therapeutic antibodies against parathyroid hormone-related peptide (PTHrP) inhibit the growth of established skeletal metastasis in mice transplanted with human triple negative breast cancer cell lines

Jiarong Li, Anne Camirand, Mahvash Zakikhani, Karine Sellin, Richard Kremer
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 520.
https://doi.org/10.1158/1538-7445.AM2020-520
Published: 15 August 2020
View articletitled, Abstract 520: Therapeutic antibodies against parathyroid hormone-related peptide (PTHrP) inhibit the growth of established skeletal metastasis in mice transplanted with human triple negative breast cancer cell lines
Journal Articles

Abstract LB-024: Inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1): evidence for impaired vitamin D signaling in an MMTV-PYMT mouse model of breast cancer

Sylvester Jusu, John Presley, Bertrand Jean-Claude, Ursula Stochaj, Richard Kremer
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): LB-024.
https://doi.org/10.1158/1538-7445.AM2019-LB-024
Published: 01 July 2019
View articletitled, Abstract LB-024: Inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1): evidence for impaired vitamin D signaling in an MMTV-PYMT mouse model of breast cancer
Journal Articles

Abstract 2632: Identification of PTHrP as a biomarker of short survival & brain metastasis in a tissue microarray retrospective analysis of triple-negative breast cancer

Gloria Assaker, Anne Camirand, Bassam Abdulkarim, Atilla Omeroglu, Jean Deschenes, Leon Van Kempen, Richard Kremer, Siham Sabri
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 2632.
https://doi.org/10.1158/1538-7445.AM2018-2632
Published: 01 July 2018
View articletitled, Abstract 2632: Identification of PTHrP as a biomarker of short survival & brain metastasis in a tissue microarray retrospective analysis of triple-negative breast cancer
Journal Articles

Abstract 3062: Ablation of parathyroid hormone-related protein in the triple negative human breast cancer line MDA-MB-231 inhibits its cancer stem cell phenotype

Jiarong Li, Louis Doré-Savard, Karine Sellin, Anne Camirand, Richard Kremer
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 3062.
https://doi.org/10.1158/1538-7445.AM2018-3062
Published: 01 July 2018
View articletitled, Abstract 3062: Ablation of parathyroid hormone-related protein in the triple negative human breast cancer line MDA-MB-231 inhibits its cancer stem cell phenotype
Journal Articles

Abstract 1995: PTHrP drives tumor initiation signaling pathways in the PyMT model of breast cancer progression

Rui Zhang, Jiarong Li, Dunarel Badescu, Andrew Karaplis, Jiannis Ragoussis, Richard Kremer
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 1995.
https://doi.org/10.1158/1538-7445.AM2018-1995
Published: 01 July 2018
View articletitled, Abstract 1995: PTHrP drives tumor initiation signaling pathways in the PyMT model of breast cancer progression
Journal Articles

Abstract 2598: In silico gene expression analysis of PTHrP and its association with molecular subtypes and organ-specific metastasis in human triple-negative breast cancer

Gloria Assaker, Anne Camirand, Siham Sabri, Richard Kremer
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 2598.
https://doi.org/10.1158/1538-7445.AM2018-2598
Published: 01 July 2018
View articletitled, Abstract 2598: In silico gene expression analysis of PTHrP and its association with molecular subtypes and organ-specific metastasis in human triple-negative breast cancer
Journal Articles

Abstract 4775: PTHrP regulate CSC and promote EMT in the PyMT model of breast cancer progression

Rui Zhang, Jiarong Li, Andrew C. Karaplis, Richard Kremer
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 4775.
https://doi.org/10.1158/1538-7445.AM2017-4775
Published: 01 July 2017
View articletitled, Abstract 4775: PTHrP regulate CSC and promote EMT in the PyMT model of breast cancer progression
Journal Articles

Abstract 89: Parathyroid Hormone-related Protein (PTHrP) is critical for breast tumour metastasis and may constitute a novel target for therapeutic intervention.

Jiarong Li, Andrew C. Karaplis, Dao C. Huang, Peter M. Siegel, Anne Camirand, Xian Fang Yang1, William J. Muller, Richard Kremer
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 89.
https://doi.org/10.1158/1538-7445.AM2013-89
Published: 15 April 2013
View articletitled, Abstract 89: Parathyroid Hormone-related Protein (PTHrP) is critical for breast tumour metastasis and may constitute a novel target for therapeutic intervention.
Journal Articles

The Vitamin D Analogue EB 1089 Prevents Skeletal Metastasis and Prolongs Survival Time in Nude Mice Transplanted with Human Breast Cancer Cells

Khadija El Abdaimi, Natalie Dion, Vasilios Papavasiliou, Patrice-Etienne Cardinal, Lise Binderup, David Goltzman, Louis-Georges Ste-Marie, Richard Kremer
Journal: Cancer Research
Cancer Res (2000) 60 (16): 4412–4418.
Published: 01 August 2000
View articletitled, The Vitamin D Analogue EB 1089 Prevents Skeletal Metastasis and Prolongs Survival Time in Nude Mice Transplanted with Human Breast Cancer Cells
Open the PDF for The Vitamin D Analogue EB 1089 Prevents Skeletal Metastasis and Prolongs Survival Time in Nude Mice Transplanted with Human Breast Cancer Cells in another window
Journal Articles

Reversal of Hypercalcemia with the Vitamin D Analogue EB1089 in a Human Model of Squamous Cancer

Khadija El Abdaimi, Vasiliou Papavasiliou, Shafaat A. Rabbani, Johng S. Rhim, David Goltzman, Richard Kremer
Journal: Cancer Research
Cancer Res (1999) 59 (14): 3325–3328.
Published: 15 July 1999
View articletitled, Reversal of Hypercalcemia with the Vitamin D Analogue EB1089 in a Human Model of Squamous Cancer
Open the PDF for Reversal of Hypercalcemia with the Vitamin D Analogue EB1089 in a Human Model of Squamous Cancer in another window
Journal Articles

Dysregulation of Parathyroid Hormone-like Peptide Expression and Secretion in a Keratinocyte Model of Tumor Progression

Janet Henderson, Michael Sebag, Johng Rhim, David Goltzman, Richard Kremer
Journal: Cancer Research
Cancer Res (1991) 51 (24): 6521–6528.
Published: 01 December 1991
View articletitled, Dysregulation of Parathyroid Hormone-like Peptide Expression and Secretion in a Keratinocyte Model of Tumor Progression
Open the PDF for Dysregulation of Parathyroid Hormone-like Peptide Expression and Secretion in a Keratinocyte Model of Tumor Progression in another window